Home › Valeant CEO 'disappointed' in Allergan poison pill: CNBC
 

Keywords :   


Valeant CEO 'disappointed' in Allergan poison pill: CNBC

2014-04-23 15:56:28| Biotech - Topix.net

T he chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc. on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.

Tags: ceo disappointed pill poison

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 27
05.07Summary for Hurricane Beryl (AT2/AL022024)
05.07Hurricane Beryl Public Advisory Number 27
05.07Hurricane Beryl Wind Speed Probabilities Number 27
05.07Hurricane Beryl Forecast Advisory Number 27
05.07Tropical Depression Aletta Graphics
05.07Tropical Depression Aletta Forecast Discussion Number 4
More »